ATTR Amyloidosis Wild Type Clinical Trials
3 recruiting trials for ATTR Amyloidosis Wild Type. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGPhase 1 / Phase 2NCT06318260
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
The goal of this clinical trial is to test the effects of the inotropic drug named dobutamine, in patients with wild-type Transthyretin Amyoid Cardiomyopathy (ATTRwt). The main...
Sponsor: Steen Hvitfeldt PoulsenEnrolling: 351 location
RECRUITINGNCT06836011
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence,...
The objective of this prospective registry study is to comprehensively characterize the prevalence, (semi-) quantitative parameters, and associated clinical outcomes of mitral...
Sponsor: Medical University of ViennaEnrolling: 6008 locations
RECRUITINGNCT06458374
ATTR Cardiac Amyloidosis in a Selected Population
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be...
Sponsor: Helse Møre og Romsdal HFEnrolling: 1801 location